isoborneol has been researched along with nimodipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, X; Liao, Q; Wu, C; Xie, Z; Xu, X; Yao, M; Zhou, Y | 1 |
| Hu, Q; Jiang, Y; Li, H; Ma, X; Wang, J; Wei, S; Wen, J; Zhang, W | 1 |
2 other study(ies) available for isoborneol and nimodipine
| Article | Year |
|---|---|
Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.
Topics: Animals; Area Under Curve; Biotransformation; Brain; Calcium Channel Blockers; Camphanes; Chromatography, High Pressure Liquid; Drug Interactions; Injections, Intravenous; Kidney; Liver; Male; Mice; Nimodipine; Spectrophotometry, Ultraviolet; Tissue Distribution | 2014 |
l-Borneol ameliorates cerebral ischaemia by downregulating the mitochondrial calcium uniporter-induced apoptosis cascade in pMCAO rats.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium Channels; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Infarction, Middle Cerebral Artery; Isocitrate Dehydrogenase; Male; Neuroprotective Agents; Nimodipine; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |